Xenon (XENE) has released an update.
Xenon Pharmaceuticals, a company dedicated to developing treatments for neurological and psychiatric disorders, will be presenting at the Goldman Sachs 45th Annual Global Healthcare Conference in Miami on June 12, 2024. The presentation by the President and Chief Commercial Officer will be available via live webcast, with a replay posted on the company’s website afterward. Xenon continues to make strides in addressing unmet medical needs in areas like epilepsy and depression.
For further insights into XENE stock, check out TipRanks’ Stock Analysis page.
